Page last updated: 2024-11-12

agosterol a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

agosterol A: from marine sponge Spongia sp. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10348156
CHEMBL ID82446
MeSH IDM0391747

Synonyms (13)

Synonym
agosterol a
CHEMBL82446
ytc6258tar ,
213549-32-7
cholest-7-ene-3,4,6,11,22-pentol, 3,4,6-triacetate, (3beta,4beta,5alpha,6alpha,11alpha,22r)-
unii-ytc6258tar
Q15410233
[(3s,4r,5s,6s,9r,10r,11r,13r,14r,17r)-4,6-diacetyloxy-11-hydroxy-17-[(2s,3r)-3-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] acetate
cholest-7-ene-3,4,6,11,22-pentol, 3,4,6-triacetate, (3beta,4beta,5alpha,6alpha,11alpha,22r)-
(1r,3ar,5s,5as,6r,7s,9ar,9br,10r,11ar)-6,7-bis(acetyloxy)-10-hydroxy-1-[(2s,3r)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-5-yl acetate
cholest-7-ene-3,4,6,11,22-pentol, 3,4,6-triacetate, (3.beta.,4.beta.,5.alpha.,6.alpha.,11.alpha.,22r)-
DTXSID701045583
AKOS040750203

Research Excerpts

Overview

Agosterol A (AG-A) is a novel agent that reverses P-glycoprotein (P-gp) and multidrug resistance protein-1 (MRP1)-meditated multidrugged resistance (MDR)

ExcerptReferenceRelevance
"Agosterol A (AG-A) is a novel agent that reverses P-glycoprotein (P-gp) and multidrug resistance protein-1 (MRP1)-meditated multidrug resistance (MDR). "( Binding site(s) on P-glycoprotein for a newly synthesized photoaffinity analog of agosterol A.
Akiyama, S; Aoki, S; Baba, M; Furukawa, T; Haraguchi, M; Kobayashi, M; Mitsuo, M; Nagata, Y; Nakajima, Y; Noguchi, T; Ren, XQ; Sumizawa, T, 2003
)
1.99
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID95342The compound was evaluated to Inhibit the growth of KB CV-60 cells at 3 ug/mL in the presence of vincristine (0.1 ug/ML)2000Bioorganic & medicinal chemistry letters, Nov-20, Volume: 10, Issue:22
Synthesis and evaluation of 4-deacetoxyagosterol A as an MDR-modulator.
AID94002Cytotoxicity was evaluated against KB-3-1 cells at 10 ug/mL2000Bioorganic & medicinal chemistry letters, Nov-20, Volume: 10, Issue:22
Synthesis and evaluation of 4-deacetoxyagosterol A as an MDR-modulator.
AID94185The compound was evaluated to Inhibit the growth of KB-C2 cells at 1 ug/mL n the presence of colchicine (0.1 ug/ML)2000Bioorganic & medicinal chemistry letters, Nov-20, Volume: 10, Issue:22
Synthesis and evaluation of 4-deacetoxyagosterol A as an MDR-modulator.
AID356408Inhibition of chymotrypsin like activity of partially purified rat liver proteasome2003Journal of natural products, Sep, Volume: 66, Issue:9
New polyhydroxy sterols: proteasome inhibitors from a marine sponge Acanthodendrilla sp.
AID680575TP_TRANSPORTER: inhibition of MTX uptake (MTX: 1 uM, AG-A: 1000 uM) in membrane vesicles from MRP3-expressing HEK293 cells2001Cancer research, Oct-01, Volume: 61, Issue:19
Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport.
AID94187The compound was evaluated to Inhibit the growth of KB-C2 cells at 3 ug/mL n the presence of colchicine (0.1 ug/ML)2000Bioorganic & medicinal chemistry letters, Nov-20, Volume: 10, Issue:22
Synthesis and evaluation of 4-deacetoxyagosterol A as an MDR-modulator.
AID95341The compound was evaluated to Inhibit the growth of KB CV-60 cells at 10 ug/mL in the presence of vincristine (0.1 ug/ML)2000Bioorganic & medicinal chemistry letters, Nov-20, Volume: 10, Issue:22
Synthesis and evaluation of 4-deacetoxyagosterol A as an MDR-modulator.
AID94186The compound was evaluated to Inhibit the growth of KB-C2 cells at 10 ug/mL in the presence of colchicine (0.1 ug/ML)2000Bioorganic & medicinal chemistry letters, Nov-20, Volume: 10, Issue:22
Synthesis and evaluation of 4-deacetoxyagosterol A as an MDR-modulator.
AID356410Cytotoxicity against human HeLa cells after 3 days by MTT assay2003Journal of natural products, Sep, Volume: 66, Issue:9
New polyhydroxy sterols: proteasome inhibitors from a marine sponge Acanthodendrilla sp.
AID95340The compound was evaluated to Inhibit the growth of KB CV-60 cells at 1 ug/mL in the presence of vincristine (0.1 ug/ML)2000Bioorganic & medicinal chemistry letters, Nov-20, Volume: 10, Issue:22
Synthesis and evaluation of 4-deacetoxyagosterol A as an MDR-modulator.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.91 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index5.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]